Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial
A Phase 3 trial for Northwest Biotherapeutics’s DCVax-L vaccine extended survival in patients with gliobastoma for many months, or in some cases, years: according to new data.
Archives for November 21, 2022
NextCure and LegoChem Biosciences team up to develop antibody drug conjugates
NextCure and LegoChem Biosciences have announced a collaboration and co-development agreement focused on generating a B7-H4 antibody drug conjugate (ADC) and options for two additional targets.
US firm developing disease-specific maps to support precision therapeutics secures $78m in Series A
Disease mapping company, Rezo, founded by UCSF scientists, has launched with a US$78m Series A round.
Oramed inks deal to commercialize oral insulin in South Korea
Oramed Pharmaceuticals, a company focused on the development of oral drug delivery platforms, has signed an exclusive commercial distribution agreement for the Republic of Korea with local player, Medicox Co Ltd, in relation to its oral insulin candidate.